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The scientific progresses achieved, during
the twenty-first century, in molecular biol-
ogy, in cytogenetics, in the use of stem
cells in the treatment of various patholo-
gies by reprograming them (1), in medical
imaging and in surgical instrumentation
allow an avant-gardist management in the
fields of assisted reproductive medicine,
in oncology, in gynecological surgery, and
even in obstetrics. Therefore, couples can
benefit from a specific and personalized
management. This management is super-
vised by multidisciplinary teams respecting
laws of medical ethics and those of bio-
ethics. Should we still use the term of
“sterility” when such a therapeutic armada
is at our disposal?
Born in the 70s, the laparoscopic
surgery, now offers a better topographic
approach of lesions, an almost perfect
macroscopic depiction of colors. Hence,
surgeons can spare more healthy tissues
such as vessels and nerves, and thus adapt a
more conservative procedure while restor-
ing normal anatomy that is essential for
preserving fertility. Endometriosis is one
of the most obvious examples (2, 3).
These advancements were achieved owing
to new 3D imaging technologies and to
the use of CO2 laser. The advent of new
energies, i.e., RF, YAG laser, Argon laser,
plasma energy, excimer, etc., opened new
perspectives for surgical management of
diseases.
The miniaturization of instruments in
hysteroscopy coupled with the develop-
ment of hydrosonography allowed a better
exploration of the uterine cavity, endome-
trial biopsies, and resection of intra-uterine
lesions. Thus preventing invasive and radi-
cal treatments and reducing post-operative
morbidity.
However, the greatest advancements
have been realized in cellular and molecular
biology, in cytogenetics, and in proteomics.
Indeed, the recent knowledge in the field
of stem cells and their specific reprogram-
ing expand horizons to gene and cell ther-
apy. A simple cell could be considered as a
treatment by re-colonizing unhealthy tis-
sues, thus preventing transplantation (1,
4, 5). The cryopreservation of ovarian tis-
sue by vitrification before radiotherapy or
chemotherapy in case of cancer gives a
new hope to those couples touched by the
disease.
The in vitro culture of pathologi-
cal cells, disease modeling, and collec-
tion of withdrawn tissues pre-operatively
allows researchers to understand etiophys-
iopathogeny, and natural evolution of the
disease as in endometriotic tissues (2).
These procedures will avoid long, expen-
sive, and ethically questionable studies on
animal models, thus allowing pharma-
cotesting. Therefore, this will help defin-
ing new disease classification and propose
therapeutic algorithms.
Owing to progress in the field of infer-
tility and assisted reproductive techniques
(ART), i.e., intra cytoplasmic spermato-
zoid injection (ICSI) and vitrification of
oocytes and embryos, increasing num-
bers of patients could be treated. In vitro
endometrial culture leads to identification
of reasons for treatment failure. Regarding
pre-implantation genetic diagnosis (PGD),
the progress in the knowledge of genetic
mapping offers much hope to patients
and couples suffering from family and
hereditary diseases.
A better knowledge of human papil-
loma viruses (HPV) and the conception of
vaccination against those HPV contribute
in the reduction of the prevalence of cer-
vical cancer, since HPV is involved in the
genesis of cervical dysplasia and thus in
that of cervical cancer. A radical treat-
ment of cervical dysplasia (surgical or laser
CO2 conization) prevents their transfor-
mation toward an invasive cervical can-
cer. The use of CO2 laser coupled with
colposcopy allowed “see-and-treat” man-
agement of cervical, vaginal, vulvar, and
perineal lesions related to HPV in an
ambulatory way with a minimal morbid-
ity. Eradication of cervical cancer during
this century is possible and conceivable,
only if national programs of information
of gynecologists, family practitioners, as
well as a program of HPV vaccination are
settled.
In case of voiding dysfunction, stress
urinary incontinence, overactive bladder,
the innovations in the field of pressure
sensors improved urodynamic measure-
ments. A new clinical approach based
on an itemized analysis of symptoms
associated with progress of urodynamic
tools allows a better therapeutic approach
including both surgery and medical
treatment.
MRI, computerized mammography, 3D
ultrasound, stereotactic, and ultrasound
guided biopsies of breast lesions eased
and fastened the diagnosis of breast can-
cer, with less morbidity. All these imaging
techniques contributed to a better man-
agement of gynecological cancers and thus
improved survival rates in these patients.
Sentinel axillary lymph node biopsy with
intra-operative frozen section allows to
ovoid the systematically axillary lymph
node resection. Protocols such as “ONCO-
TYPE,” based on cellular phenotyping, pre-
dict the need for chemotherapy. As an
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example, Her-2–Neu is used as a marker
of poor prognosis and indicator for the
use of HERCEPTIN neoadjuvant treat-
ment. Radiotherapy becomes more focused
on the tumor site, thus avoiding over-
doses of irradiation and reducing side
effects. Hormonal therapy is possible due
to immunochemistry analysis of tumor-
estrogen and -progesterone receptors, thus
offering a longer period without recur-
rence. In case of mixed ovarian tumors,
immunohistochemistry allows an accurate
diagnosis.
In the fields of contraception, a lot
of progress has been achieved such
as Levonorgestrel intra-uterine devices,
progestogens of third and fourth gen-
eration allowing a decrease in ethinyl-
estradiol dosage, progestogens implants,
vaginal rings, and transdermal patches.
So women have a very wide choice and
contraception can be individually adapted.
Gynecology is in constant progress
allowing an ambulatory management with
less morbidity thus reduced health costs, an
earlier diagnosis with a better adapted and
personalized treatment leading to higher
survival rates.
Obstetrics also knew considerable
progresses. Since the twentieth century,
prenatal diagnosis of congenital malfor-
mations and genetic diseases is made
easier and earlier, a tribute of progresses
in the fields of ultrasound, amniocente-
sis, and chorionic villi sampling (CVS),
thus allowing an optimal management
with less morbidity and less psychologi-
cal disturbance in the respect of national
legal frames. These great achievements
could not be possible without progress in
genetics and biology. Many markers are
currently studied to screen earlier patients
predisposed to develop preeclampsia dur-
ing pregnancy or to predict premature
rupture of membranes and labor, thus pre-
venting wet lung syndrome. Progresses in
neonatal resuscitation decreased perinatal
morbidity and mortality. The detection
of fetal DNA in the maternal blood
with the hope of the complete genome
fetal sequencing represents another
breakthrough.
Henceforth, in utero fetal surgery as
a vesico-amniotic shunting (a twin–twin
transfusion syndrome with Laser ablation
of vessels), the treatment of fetal blad-
der obstructions, an aortic or pulmonary
valvuloplasty (opening the aortic or pul-
monary fetal heart valves to allow blood
flow) (6), an atrial septostomy (open-
ing the inter-atrial septum of the fetal
heart to allow unrestricted blood flow
between the atriums), the surgical treat-
ment of a congenital diaphragmatic her-
nia by a Balloon tracheal occlusion and
the treatment of spina bifida with a clo-
sure of the malformation entered clinical
practice.
Epidural anesthesia, the new standard-
ized criteria of fetal heart rate analysis, the
advent of the STAN,the analysis of scalp pH
contributed to the improvement of peri-
natal prognosis. Techniques of emboliza-
tion contributed to a less aggressive, but
effective, treatment of post-partum hem-
orrhage, thus saving lives and sparing
uteri.
With such a therapeutic arsenal, there
should be no more fatality. However ques-
tions arise, among them“should we go back
to a more physiological or natural practice
of obstetrics?” or “why the rate of cesarean
sections increased, and all this technology
is available?” Even though we cannot com-
promise progresses, the question is to be
debated.
In both gynecology and obstetrics, opti-
mal training of the nurses, midwifes, and
residents is essential. In these fields, specific
simulators are ideal tools to start, maintain,
and develop skills. Finally, internet and
other media are obvious tools to enhance
knowledge for patients, doctors, midwives,
and nurses.
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